斯科丁:对其药理学,药理动力学和毒性的综述
Xiao-Yan Gao1,2,3, Xu-Yang Li1,2, Cong-Ying Zhang1,2,3
1Basic Medicine College, Chifeng University, Chifeng, China.
Frontiers in pharmacology
|March 11, 2024
概括
斯科波素是一种植物性氨酸,具有广泛的治疗潜力,具有抗微生物,抗癌和神经保护性质. 需要进一步的研究来优化其生物可用性并探索其完整的药用应用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 药用化学 医学化学
背景情况:
- 斯科波是天然存在的氨酸,在各种药用和食用植物中发现.
- 它具有广泛的药理活性,包括抗微生物,抗癌,抗炎,抗氧化和神经保护作用.
- 斯科波还可以作为一种主要酶的抑制剂,如乙胆酶和单胺氧化酶.
研究的目的:
- 提供关于 scopoletin 的药理学,药理动力学和毒性的全面审查.
- 评估 scopoletin 作为候选药物的治疗潜力和未来前景.
- 评估 scopoletin 作为一种用于开发新型治疗药物的化合物的适用性.
主要方法:
- 关于 scopoletin 的体外和体内实验研究的文献综述.
- 对药理学数据的分析,包括酶抑制和各种生物活动.
- 从现有研究中对药理动力学概况和毒性评估的评估.
主要成果:
- 斯科波丁具有显著的抗微生物,抗癌,抗炎,抗血管,抗氧化,抗糖尿病,抗高血压,抗肝保护和神经保护性质.
- 药物动力学研究表明生物利用率低,吸收快,代谢广泛,可能是由于水溶性差.
- 毒性研究表明,在治疗剂量下, scopoletin 对大多数测试的细胞类型是无毒的.
结论:
- 斯科丁作为治疗癌症,肝脏疾病,糖尿病,神经退行性疾病和精神健康状况的候选药物具有相当大的潜力.
- 其有利的药理特征和低毒性使其成为开发新型,有效和更安全的衍生物的有希望的化合物.
- 对其分子机制,毒性和口服生物利用性的进一步研究是有必要的,以充分实现其治疗价值.
更多相关视频
相关概念视频
01:10Pharmacokinetics: Overview
6.4K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
6.4K
01:19Nonlinear Pharmacokinetics: Overview
368
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
368
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
01:22Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
171
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
171
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:26Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K